O. Chazoullières

mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors.

V. Mazzaferro, I. Bilbao, U. Settmacher, 2020, Annals of surgery.

Factors associated with recurrence after transplantation for hepatocellular carcinoma

F. Roudot-thoraval, D. Dhumeaux, F. Durand, 2003 .

Prediction of survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) using the TNM staging classification modified for LT: Validation in a French cohort

F. Roudot-thoraval, D. Dhumeaux, K. Boudjema, 2003 .